Abstract: The present invention relates to a von Willebrand factor composition for the prevention and/or the treatment of haemorrhage and/or bleeding in patients with mechanical circulatory support.
Type:
Application
Filed:
April 6, 2016
Publication date:
April 26, 2018
Applicants:
Laboratoire Francais du Fractionnement des Biotechnologies, CTRE Hospitalier Universitaire de Lille, Universite Lille 2 Droit et Sante
Inventors:
Sophie SUSEN, Andre VINCENTELLI, Eric VAN BELLE, Antoine RAUCH, Flavien VINCENT